| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 11/11/2009 | CN101575311A Method for preparing epiphysin |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574519A Method for preventing or treating opiate resistance and dependency |
| 11/11/2009 | CN101574518A Hapten-carrier conjugates and uses thereof |
| 11/11/2009 | CN101574500A Nutgrass galingale rhizome and nux vomica powder used for eliminating cancerous pain |
| 11/11/2009 | CN101574499A Capsule for calming heart and tranquilizing mind |
| 11/11/2009 | CN101574483A Traditional Chinese medicine preparation for treating migraine |
| 11/11/2009 | CN101574482A Traditional Chinese medicine preparation for treating blood stasis headache |
| 11/11/2009 | CN101574481A Traditional Chinese medicine preparation for treating Qi deficiency and dizziness headache |
| 11/11/2009 | CN101574466A Traditional Chinese medicine preparation for treating cold headache |
| 11/11/2009 | CN101574457A Traditional Chinese medicine composition for curing epilepsy |
| 11/11/2009 | CN101574452A Traditional Chinese medicine preparation for treating wind heat headache |
| 11/11/2009 | CN101574451A Traditional Chinese medicine preparation for treating rheumatic headache |
| 11/11/2009 | CN101574444A Rehabilitation medication combination for curing addiction to morphine drugs and preparation method thereof |
| 11/11/2009 | CN101574443A Rehabilitation medication combination for curing addiction to morphine drugs and preparation method thereof |
| 11/11/2009 | CN101574427A Traditional Chinese medicine compound for aiding drug rehabilitation and traditional Chinese medicine containing same |
| 11/11/2009 | CN101574400A Chinese medicament containing gen-seng and cordyceps |
| 11/11/2009 | CN101574395A Method for producing schisandra extract by adopting high voltage pulse electric field technology |
| 11/11/2009 | CN101574394A Strychnos alkaloid vesicle and preparation method thereof |
| 11/11/2009 | CN101574392A Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid |
| 11/11/2009 | CN101574391A Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside |
| 11/11/2009 | CN101574383A Prevention and treatment of diseases induced by microcirculation disturbance with panax notoginoside |
| 11/11/2009 | CN101574364A Preparation capable of improving intelligence, height, athletic ability and immunity and preparation method |
| 11/11/2009 | CN101574360A Application of epimedin in preparing medicines for treating diseases where estrogen needs supplementing |
| 11/11/2009 | CN101574348A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing |
| 11/11/2009 | CN101574347A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing |
| 11/11/2009 | CN101574341A Oral solid medicine composition containing ropinirole |
| 11/11/2009 | CN101574330A Rizatriptan benzoate film agent |
| 11/11/2009 | CN101574329A Zolpidem tartrate film agent |
| 11/11/2009 | CN101574328A Timing pulsed release micro-pill of zolpidem salt |
| 11/11/2009 | CN100558744C Use of a recombinant erythropoietin having high activity and reduced side effects |
| 11/11/2009 | CN100558728C Calcitonin gene related peptide receptor antagonists |
| 11/11/2009 | CN100558718C Piperazinyl and diazapanyl benzamides and benzthioamides |
| 11/11/2009 | CN100558717C Novel medicine |
| 11/11/2009 | CN100558715C Protein kinase inhibitors |
| 11/11/2009 | CN100558712C Therapeutic molecules and methods-1 |
| 11/11/2009 | CN100558428C Calcitonin gene related peptide receptor antagonists |
| 11/11/2009 | CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/11/2009 | CN100558397C Methods of treating neurological conditions with hematopoeitic growth factors |
| 11/11/2009 | CN100558393C Chinese medicine for eliminating drug addiction and its preparation process |
| 11/11/2009 | CN100558371C Application of Chinese medicine composition in treating cardiac and cerebral vascular diseases |
| 11/11/2009 | CN100558366C Use of oligose ester in preventing and treating depression |
| 11/11/2009 | CN100558365C Conjugated anti-psychotic drugs and uses thereof |
| 11/11/2009 | CN100558350C Improved transdermal delivery system |
| 11/10/2009 | US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease |
| 11/10/2009 | US7615567 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome |
| 11/10/2009 | US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 11/10/2009 | US7615558 6-arylmethylprazolo[3,4-d]pyrimidines |
| 11/10/2009 | US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation |
| 11/10/2009 | US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 11/10/2009 | US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 11/10/2009 | US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 11/10/2009 | US7615383 Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies |
| 11/10/2009 | US7615207 Methods for treating irritable bowel syndrome |
| 11/10/2009 | CA2513064C Nanoparticulate topiramate formulations |
| 11/10/2009 | CA2481482C Tropane derivatives as ccr5 modulators |
| 11/10/2009 | CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders |
| 11/10/2009 | CA2419887C Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 11/10/2009 | CA2416785C Novel arylethene-sulfonamides |
| 11/10/2009 | CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 11/10/2009 | CA2408292C Method for the preparation of citalopram |
| 11/10/2009 | CA2396351C New therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders |
| 11/10/2009 | CA2382117C 4-substituted piperidine compound |
| 11/10/2009 | CA2378792C Aminothiazole derivatives and their use as crf receptor ligands |
| 11/10/2009 | CA2368352C Method for treating neurodegeneration |
| 11/10/2009 | CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 11/05/2009 | WO2009134958A2 Dog pheromone formulation and delivery system |
| 11/05/2009 | WO2009134877A2 Therapeutics for treatment resistant mental disorders |
| 11/05/2009 | WO2009134666A1 Indazole compounds as ccr1 receptor antagonists |
| 11/05/2009 | WO2009134617A1 Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease |
| 11/05/2009 | WO2009134383A2 Vinyl substituted fatty acids |
| 11/05/2009 | WO2009134203A1 New peptidomimetic compounds |
| 11/05/2009 | WO2009134131A1 Role of (de)acetylation in counteracting protein aggregation |
| 11/05/2009 | WO2009133970A1 Crystalline compound |
| 11/05/2009 | WO2009133831A1 Phenylpropionic acid derivative and use thereof |
| 11/05/2009 | WO2009133692A1 Quinoline compound |
| 11/05/2009 | WO2009133686A1 Medicaments for treating alzheimer's disease |
| 11/05/2009 | WO2009133586A1 Remedy for alzheimer's disease |
| 11/05/2009 | WO2009133573A2 A homeopathic formulation |
| 11/05/2009 | WO2009133522A1 Piperidine and pyrrolidine compounds |
| 11/05/2009 | WO2009133521A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
| 11/05/2009 | WO2009133247A1 Neurotrophic factor manf and uses thereof |
| 11/05/2009 | WO2009133142A1 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response |
| 11/05/2009 | WO2009133141A2 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis |
| 11/05/2009 | WO2009133135A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethyl phenyl) methylcarboxamides as nk1 tachikynin receptor antagonists |
| 11/05/2009 | WO2009133128A1 Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate |
| 11/05/2009 | WO2009133110A1 Modulators of dopamine neurotransmission |
| 11/05/2009 | WO2009133109A1 Modulators of dopamine neurotransmission |
| 11/05/2009 | WO2009133107A1 Modulators of dopamine neurotransmission |
| 11/05/2009 | WO2009133097A1 Preparation of n-6 demethylated, 9-10-dihydrolysergic acid alkyl esters |
| 11/05/2009 | WO2009132478A1 Synthesis of timosaponin bii |
| 11/05/2009 | WO2009132463A1 New deodorization method and organoleptic improvement of marine oil extracts |
| 11/05/2009 | WO2009105641A3 Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
| 11/05/2009 | WO2009091898A3 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| 11/05/2009 | WO2009046879A3 Use of the combination of npy and nociceptin as a therapeutic agent |
| 11/05/2009 | WO2009043526A3 Use of gip ( 6-30) alone or in combination with hgh as a therapeutic agent |
| 11/05/2009 | WO2009040051A9 Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent |
| 11/05/2009 | WO2009040005A9 Use of the peptide rfmwmr as a therapeutic agent |
| 11/05/2009 | WO2009034433A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
| 11/05/2009 | WO2009033819A3 Use of glicentin-related polypeptide and apelin- 13 in combination as therapeutic agents, eg for treating aids |